The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

N•••••••• L••

Pharmaceuticals, Biotechnology & Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $6.1M
sum of BDC pieces, a lower bound
Fair value
$5.5M
95c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
May 15, 2027
$6.1M inside 24 months
On the tape since
Jun 30, 2026
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $6.1M95cSOFR+650 bp
PIK 50.00%
May 15, 20271
Equity pieces beside the debt: preferred equity ($5,000 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
R••••• G••••• F•••••• C••••preferred equity equity
W••••••• & O•••• C••••••••• R••••• Investment T••• W•••••• S••••• B-2 P•••••••• S•••• I•••
Not disclosed$5,000
167c
R••••• G••••• F•••••• C••••term loan first lien
Investment T••• S••••• S•••••• I••••••• R••• S•••+6.50%13.50%floor 50%C••• 50%PIK 9.66%ETP
$6.1M$5.5M
95c
SOFR+650 bp
PIK 50.00%
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$6.1M$5.5M95c1
What changed
Every change including routine ones
Identity
Group key
NEOLIGHTderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Pharmaceuticals, Biotechnology & Life Sciencesreportedas one filer wrote it